Which combination therapy strategy for "naive" patients with chronic hepatitis C is the most cost-effective?.

被引：0
|
作者：
Buti, M
Casado, MA
Medina, M
Fosbrook, L
Esteban, R
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
[2] Schering Plough Corp, Madrid, Spain
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1016
引用
收藏
页码：426A / 426A
页数：1
相关论文
共 50 条
  • [1] Which is the most cost-effective combination therapy strategy for naive patients with chronic hepatitis C?
    Buti, M
    Casado, MA
    Fosbrook, L
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2001, 34 : 162 - 162
  • [2] Which is the most cost-effective combination therapy strategy using interferon α-2b plus ribavirin for naive patients with chronic hepatitis C?
    Buti, M
    Casado, MA
    Fosbrook, L
    Esteban, R
    CLINICAL DRUG INVESTIGATION, 2002, 22 (01) : 31 - 39
  • [3] Which is the Most Cost-Effective Combination Therapy Strategy Using Interferon α-2b plus Ribavirin for Naïve Patients with Chronic Hepatitis C?
    Maria Buti
    Miguel A. Casado
    Leslie Fosbrook
    Rafael Esteban
    Clinical Drug Investigation, 2002, 22 : 31 - 39
  • [4] Therapy a la carte is more cost-effective than standard combination therapy for naive patients with chronic hepatitis C
    Buti, Maria
    Casado, Miguel A.
    Esteban, Rafael
    HEPATOLOGY, 2006, 44 (04) : 324A - 325A
  • [5] How adherence to the therapy with peginterferon plus ribavirin is cost-effective in naive patients with chronic hepatitis C?.
    Buti, M
    Medina, M
    Casado, MA
    Fosbrook, L
    Esteban, R
    HEPATOLOGY, 2002, 36 (04) : 601A - 601A
  • [6] Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
    Buti, M
    Casado, MA
    Fosbrook, L
    Wong, JB
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2000, 33 (04) : 651 - 658
  • [7] Which is the most cost-effective combination therapy using interferon alfa-2b plus ribavirin for non-responder patients with chronic hepatitis C?.
    Ricardo, MO
    Carmen, A
    Angel, CM
    Leslie, F
    HEPATOLOGY, 2002, 36 (04) : 577A - 577A
  • [8] Is Peg-interferon plus Ribavirin a cost-effective therapy, and if so, what is the most efficient way to use this therapy in naive patients with chronic hepatitis C?
    Buti, M
    Casado, MA
    Medina, M
    Fosbrook, L
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2002, 36 : 101 - 101
  • [9] The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy
    Garcia, Federico
    Dominguez-Hernandez, Raquel
    Casado, Marta
    Macias, Juan
    Tellez, Francisco
    Manuel Pascasio, Juan
    Angel Casado, Miguel
    Carlos Alados, Juan
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2019, 37 (10): : 634 - 641
  • [10] A pragmatic and cost-effective strategy of a combination therapy of interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C
    Sagmeister, M
    Wong, JB
    Mullhaupt, B
    Renner, EL
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (05) : 483 - 488
12345